Accessibility Menu

Retrieve Medical(OTC) PKPH

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2023)-47%
5 Year-95%
1 Year-2%
1 Month+0%
N/A
Retrieve Medical last closing stock price
MetricPriceDate
Last closeUSD 0.982026-08-28
Retrieve Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.87%USD 1.002026-08-18
1 month+0.13%USD 0.982026-07-28
3 month-9.97%USD 1.092026-05-29
Year to date-40.26%USD 1.642025-12-31
1 year-1.87%USD 1.002025-08-28
3 year-66.28%USD 2.912023-08-29
5 year-94.72%USD 18.602021-08-27
Since inception-46.96%USD 1.852023-03-28

Retrieve Medical Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$4.31

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Sep 13, 2017

PKPH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Retrieve Medical

Peak Pharmaceuticals, Inc. is an American bio-pharmaceutical and nutraceutical company focused on developing therapeutic products derived from hemp extracts. The company specializes in formulating THC-free, hemp-based remedies aimed at alleviating symptoms associated with inflammatory and auto-immune conditions.

Products and Services
  • Development of over-the-counter, THC-free hemp remedies
  • Manufacturing and marketing of therapeutic products
  • Focus on products for inflammatory and auto-immune conditions
Growth Outlook
  • Established in 2007, with a rebranding in 2014, showing commitment to innovation
  • Market demand for hemp-based products continues to rise
  • Potential for expansion into new therapeutic areas and markets
Financial Highlights
  • Market capitalization of approximately $607 million
  • Stock price range over the past year: $1.35 to $43.8
  • Beta of 0.56 indicates lower volatility compared to the overall market
Peak Pharmaceuticals, Inc. operates in a growing sector, with increasing consumer interest in natural remedies. The company's focus on THC-free products positions it well within the expanding market for hemp-based therapies. With a solid market capitalization and a relatively stable stock price, Peak Pharmaceuticals presents an intriguing opportunity for investors interested in the bio-pharmaceutical and nutraceutical industries. The company's commitment to innovation and potential for market expansion further enhances its attractiveness as a long-term investment.
AI Generated • Aug 14, 2026

Industry

Biotechnology

CEO

Jerry E. Swon

Headquarters

Scottsdale, AZ 85260, US

PKPH Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Retrieve Medical Performance Analysis

Retrieve Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 7,500N/A
20252025-12-31USD 22,500200.0%
Retrieve Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30USD -0.42117.5%
20232023-12-31USD -0.19-55.0%
20242024-12-31USD -0.17-12.4%
20252025-12-31USD -0.11-34.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

+0.0%

Gross Profit

-$0.00

-0.1%

Gross Margin

92.54%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-$2.20

+3.6%

EBITDA

-$2.11

+3.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$0.63

-34.1%

Total Debt

$0.44

+0.9%

Accounts Receivable

N/A

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.44

+0.9%

Return on Assets

-1071.36%

+1.5%

Return on Invested Capital

57.67%

+1.2%

Free Cash Flow

-$0.43

+1.8%

Operating Cash Flow

-$0.43

+1.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
QFTAQuantum FinTech Acquisition Corporation
$10.26+51.33%
MYCBMy City Builders, Inc.
$0.11+0.00%
AESOAtlantic Energy Solutions, Inc.
$0.01+0.00%
CNCTChina Teletech Holding, Inc.
$200.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
WETOWetour Robotics
$5.48-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$71.92+0.00%
INTCIntel
$89.51+0.00%
IBITiShares Bitcoin Trust
$44.67+0.02%

Questions About PKPH

What is the current price of Retrieve Medical?

Retrieve Medical is trading at N/A per share.

What is the 52-week range for Retrieve Medical?

Over the past 52 weeks, Retrieve Medical has traded between N/A and N/A.

How much debt does Retrieve Medical have?

As of the most recent reporting period, Retrieve Medical reported total debt of $438.00K.

How much cash does Retrieve Medical have on hand?

Retrieve Medical reported $190.22K in cash and cash equivalents in its most recent financial results.

What is Retrieve Medical’s dividend yield?

Retrieve Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.